To evaluate the role of TGFBI in the treatment effects of hUC-MSCs in T1DM mice, sh-TGFBI-MSCs and sh-NC-MSCs were intravenously administered to STZ-induced T1DM mice (Fig. 2a). Here, TGFBI is linked to type 1 diabetes mellitus.